We are live on ! Find out more
FOLD

Amicus Therapeutics

Delisted

FOLD was delisted on the 24th of April, 2026.

139 hedge funds and large institutions have $1.34B invested in Amicus Therapeutics in 2015 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 64 increasing their positions, 35 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 35

6% more call options, than puts

Call options by funds: $11.3M | Put options by funds: $10.6M

5% less funds holding

Funds holding: 147139 (-8)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

18% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 34

24% less capital invested

Capital invested by funds: $1.76B → $1.34B (-$414M)

Holders
139
Holders Change
-8
Holders Change %
-5.44%
% of All Funds
3.65%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.16%
New
28
Increased
64
Reduced
35
Closed
34
Calls
$11.3M
Puts
$10.6M
Net Calls
+$675K
Net Calls Change
+$842K
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$2.08M +$30.1K +3,343 +2%
CCM
52
Convector Capital Management
New York
$2.04M +$1.9M +210,500 New
ACM
53
Asymmetry Capital Management
California
$1.89M -$340K -37,751 -16%
QI
54
QS Investors
New York
$1.89M -$22.8K -2,527 -1%
HCMT
55
Highland Capital Management (Texas)
Texas
$1.78M +$393K +43,592 +31%
TD Asset Management
56
TD Asset Management
Ontario, Canada
$1.73M +$23.4K +2,600 +1%
TA
57
Teachers Advisors
New York
$1.66M +$30.2K +3,348 +2%
CAM
58
Cormorant Asset Management
Massachusetts
$1.46M
Swiss National Bank
59
Swiss National Bank
Switzerland
$1.36M +$46K +5,100 +4%
Connor, Clark & Lunn Investment Management (CC&L)
60
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.26M -$2.28M -253,525 -66%
MCM
61
Moore Capital Management
New York
$1.21M
Susquehanna International Group
62
Susquehanna International Group
Pennsylvania
$1.17M +$400K +44,387 +58%
FAM
63
Fred Alger Management
New York
$1.16M -$2.19M -243,284 -67%
ProShare Advisors
64
ProShare Advisors
Maryland
$1.14M +$142K +15,789 +16%
CS
65
Credit Suisse
Switzerland
$1.11M +$462K +51,238 +80%
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$1.1M
NFA
67
Nationwide Fund Advisors
Ohio
$1.02M +$15.8K +1,754 +2%
RA
68
Royce & Associates
New York
$1.02M -$2.06M -228,700 -68%
BA
69
BlackRock Advisors
Delaware
$1M -$417K -46,259 -31%
QSS
70
Quantitative Systematic Strategies
Florida
$1M +$938K +104,059 New
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$911K -$82.7K -9,180 -9%
MLICM
72
Metropolitan Life Insurance Company (MetLife)
New York
$787K
AP
73
AlpInvest Partners
Netherlands
$732K +$680K +75,503 New
Bank of America
74
Bank of America
North Carolina
$703K +$250K +27,711 +62%
UBS Group
75
UBS Group
Switzerland
$617K +$176K +19,486 +44%

FOLD Hedge Fund Activity: Q4 2015 in Review

139 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2015, worth a combined $1.34B — down 24% from $1.76B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of FOLD and 28 opened new positions — a net loss of 6 holders — while 35 trimmed existing stakes and 64 added.

The largest buyer was Fidelity Investments, adding an estimated $35.5M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $38.5M sold.

  • 139 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2015, down from 147 in Q3 2015.
  • Funds reported $1.34B of Amicus Therapeutics stock for Q4 2015, down 24% quarter-over-quarter.
  • 28 funds opened new Amicus Therapeutics positions in Q4 2015 and 34 closed out, a net change of -6 holders.
  • The largest Amicus Therapeutics buyer in Q4 2015 was Fidelity Investments, an estimated $35.5M added.
  • The largest Amicus Therapeutics seller in Q4 2015 was Lord, Abbett & Co, an estimated $38.5M sold.

Based on aggregated 13F filings for Q4 2015.